Ken Griffin Bio Restorative Therapies, Inc. Transaction History
Citadel Advisors LLC
- $618 Billion
- Q3 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Bio Restorative Therapies, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 106,210 shares of BRTX stock, worth $141,259. This represents 0.0% of its overall portfolio holdings.
Number of Shares
106,210Holding current value
$141,259% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding BRTX
# of Institutions
17Shares Held
397KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA88.8KShares$118,0740.0% of portfolio
-
Geode Capital Management, LLC Boston, MA55.3KShares$73,5070.0% of portfolio
-
Wealth Alliance Mellville, NY40KShares$53,2000.01% of portfolio
-
Stone X Group Inc.37.5KShares$49,8080.0% of portfolio
-
Virtu Financial LLC New York, NY24.4KShares$32,3860.0% of portfolio
About BioRestorative Therapies, Inc.
- Ticker BRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 3,650,030
- Market Cap $4.85M
- Description
- BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtx...